Effect of MS-153 on the acquisition and expression of conditioned fear in rats

European Journal of Pharmacology

Volumn 505, Issue 1-3, 2004, Pages 145-149

  Li, Xiaobai ^a,b   Inouei, Takeshi ^a   Abekawai, Tomohiro ^a   Yirui, Fang ^a,b   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Contextual fear conditioning; Fear and anxiety; Glutamate uptake and release; MS 153; NMDA receptor antagonist

Indexed keywords

5 METHYL 1 NICOTINOYL 2 PYRAZOLINE; GLUTAMIC ACID; MS 153; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APPARATUS; ARTICLE; BEHAVIOR; BRAIN PROTECTION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXPERIMENT; FEAR; INHIBITION KINETICS; LOCOMOTION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; MALE; MOTOR ACTIVITY; NICOTINIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 8844234228     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.041     Document Type: Article

References (33)

1. T. Abekawa, M. Honda, K. Ito, T. Inoue, and T. Koyama Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine Psychopharmacology 160 2002 122 131
2. M.J. Benvenga, J.D. Leander, and P.L. Ornstein Anxiolytic effect of the competitive AMPA antagonist 215490 in a pigeon punished responding model Soc. Neurosci. 19 1993 293
3. S. Campeau, M.J. Miserendino, and M. Davis Intra-amygdala infusion of the N-methyl-d-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus Behav. Neurosci. 106 1992 569 574
4. G.L. Collingridge, and T.V.P. Bliss NMDA receptors-their role in long-term potentiation Trends Neurosci. 10 1987 288 293
5. R. Corbett, and R.W. Dunn Effects of HA-966 on conflict, social interaction and plus maze behaviour Drug Dev. Res. 24 1991 201
6. R.W. Dunn, R. Corbett, and S. Fielding Effects of 5-HT1a receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze Eur. J. Pharmacol. 169 1989 1 10
7. M.S. Fanselow Conditional and unconditional components of postshock freezing Pavlovian J. Biol. Sci. 15 1980 177 182
8. M.S. Fanselow Contextual fear, gestalt memories, and the hippocampus Behav. Brain Res. 110 2000 73 81
9. M.S. Fanselow, and J.J. Kim Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist d,l-2-amino-5-phosphonovaleric acid to the basolateral amygdala Behav. Neurosci. 108 1994 210 212
10. T. Inoue, S. Hashimoto, K. Tsuchiya, T. Izumi, T. Ohmori, and T. Koyama Effect of citalopram a selective serotonin reuptake inhibitor on the acquisition of conditioned freezing Eur. J. Pharmacol. 311 1996 1 6
11. J.H. Kehne, T.C. McCloskey, B.M. Baron, E.M. Chi, B.L. Harrison, J.P. Whitten, and M.G. Palfreyman NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalisation Eur. J. Pharmacol. 193 1991 283 292
12. M. Kim, S. Campeau, W.A. Falls, and M. Davis Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle Behav. Neural Biol. 59 1993 5 8
13. A. Klodzinska, E. Chojnacka-Wojcik, A. Palucha, P. Branski, P. Popik, and A. Pilc Potential anti-anxiety, anti-addictive effects of LY354740, a selective group II glutamate metabotropic receptors agonist in animal models Neuropharmacology 38 1999 1831 1839
14. J. Kotlinska, and S. Liljequist The putative AMPA receptor antagonist, LY326325, produces anxiolytic effects without altering locomotor activity in rats Pharmacol. Biochem. Behav. 60 1998 119 124
15. H. Lee, and J.J. Kim Amygdala NMDA receptors are critical for new fear learning in previously fear-conditioned rats J. Neurosci. 18 1998 8444 8454
16. S. Maren Long-term potentiation in the amygdala: a mechanism for emotional learning and memory Trends Neurosci. 22 1999 561 567
17. S. Maren, G. Aharonov, D.L. Stote, and M.S. Fanselow N-methyl-d-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats Behav. Neurosci. 110 1996 1365 1374
18. M.G. McKernan, and P. Shinnick-Gallagher NMDA-mediated synaptic transmission in the lateral amygdala is not potentiated in fear conditioned animals Abstr.-Soc. Neurosci. 24 1998 780
19. M.J.D. Miserendino, C.B. Sananes, K.R. Melia, and M. Davis Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala Nature 345 1990 716 718
20. T. Ohmori, T. Abekawa, A. Muraki, and T. Koyama Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine Pharmacol. Biochem. Behav. 48 1994 587 591
21. C. Redini-Del Negro, and S. Laroche Learning-induced increase in glutamate release in the dentate gyrus is blocked by the NMDA receptor antagonist AP5 Neurosci. Res. Commun. 13 1993 157 165
22. R.A. Rison, and P.K. Stanton Long-term potentiation and N-methyl-d-aspartate receptors: foundations of memory and neurological disease Neurosci. Biobehav. 1995 533 552
23. M.T. Rogan, and J.E. LeDoux LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit Neuron 15 1995 127 136
24. M.T. Rogan, U.V. Staubli, and J.E. LeDoux Fear conditioning induces associative long-term potentiation in the amygdala Nature 390 1997 604 607
25. A. Shekhar, and S.R. Keim LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats Neuropharmacology 39 2000 1139 1146
26. F. Shimada, Y. Shiga, M. Morikawa, H. Kawazura, O. Morikawa, T. Matsuoka, T. Nishizaki, and N. Saito The neuroprotective agent MS-153 stimulates glutamate uptake Eur. J. Pharmacol. 386 1999 263 270
27. W.P. Spooren, A. Vassout, H.C. Neijt, R. Kuhn, F. Gasparini, S. Roux, R.D. Porsolt, and C. Gentsch Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl) pyridine in rodents J. Pharmacol. Exp. Ther. 295 2000 1267 1275
28. K. Umemura, T. Gemba, A. Mizuno, and M. Nakashima Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion Stroke 27 1996 1624 1628
29. D.L. Walker, and M. Davis Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear J. Neurosci. 17 1997 9375 9383
30. J.L. Wiley, A.F. Cristello, and R.L. Balster Effects of site selective NMDA receptor antagonists in an elevated plus model of anxiety in mice Eur. J. Pharmacol. 294 1995 101 107
31. S.L. Young, D.L. Bohenek, and M.S. Fanselow NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure Behav. Neurosci. 108 1994 19 29
32. W.N. Zhang, T. Bast, and J. Feldon The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-d-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus Behav. Brain Res. 126 2001 159 174
33. F. Zinebi, M. McKernan, and P. Shinnick-Gallagher Expression of fear-conditioning is accompanied by increased paired-pulse depression within the amygdala Pharmacol. Biochem. Behav. 71 2002 393 400